Try our Advanced Search for more refined results

Cancer Immunotherapy Developer Cellectis Eyes $115M IPO

By Chelsea Naso (February 23, 2015, 1:13 PM EST) -- Cancer treatment developer Cellectis SA on Friday filed to raise up to $115 million in its U.S. initial public offering, as the France-based company eyes investor excitement surrounding the promise of immunotherapy treatments in the battle against the second leading cause of death in the U.S....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!